Changeflow GovPing Healthcare & Life Sciences Observational NCT07547124 QoR-15 Study Thyroide...
Routine Notice Added Final

Observational NCT07547124 QoR-15 Study Thyroidectomy Postoperative Analgesia

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

A prospective observational study has been registered on ClinicalTrials.gov (NCT07547124) to evaluate the association between postoperative analgesic approaches and recovery quality in patients undergoing elective total thyroidectomy. Patients will be followed under routine clinical care without intervention or randomization, with the primary outcome measured as Quality of Recovery-15 (QoR-15) score at 24 hours after surgery. Secondary outcomes include swallowing pain, resting pain, opioid consumption, postoperative nausea and vomiting, and additional analgesic requirement.

“This prospective observational study evaluates the association between postoperative analgesic approaches and recovery outcomes in patients undergoing elective total thyroidectomy. Patients will be followed under routine clinical care without intervention or randomization.”

Mintz , verbatim from source
Published by Mintz on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This document registers a new prospective observational study on ClinicalTrials.gov, establishing a structured framework for evaluating the relationship between analgesic interventions and postoperative recovery outcomes in thyroidectomy patients. The study uses QoR-15 as its primary endpoint, with secondary assessments of pain, opioid consumption, and nausea. Healthcare institutions and clinical investigators conducting perioperative research may find these outcomes relevant to their own quality-improvement and analgesia-protocol initiatives, though the observational design precludes causal inference about analgesic efficacy.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Postoperative Analgesia and Recovery Quality in Total Thyroidectomy

Observational NCT07547124 Kind: OBSERVATIONAL Apr 23, 2026

Abstract

This prospective observational study evaluates the association between postoperative analgesic approaches and recovery outcomes in patients undergoing elective total thyroidectomy. Patients will be followed under routine clinical care without intervention or randomization.

The primary outcome is the Quality of Recovery-15 (QoR-15) score at 24 hours. Secondary outcomes include swallowing pain, resting pain, opioid consumption, postoperative nausea and vomiting, and additional analgesic requirement.

Conditions: Postoperative Pain

Interventions: Cervical Plexus Block

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Mintz.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Mintz
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical research Postoperative care
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!